Grant: Discovery Grants Program - Individual
McGill University
$56,000.00
Biochemical development of the fetus and neonate and maternal diet
EF 2015-16
Résumé
Early nutrition plays an important role in fetal and neonatal growth and development, but surprisingly little research has investigated those nutrients and growth factors that play critical roles in these early biological processes. Historical data points to glucose as the principal metabolic fuel for the developing fetus and fetal glycogen reserves as playing a critical role in preventing neonatal morbidity and mortality including neonatal hypoglycemia. However, we now understand that early perinatal exposure to a complex array of nutrients and growth factors found in amniotic fluid (AF) and in milk, including amino acids, fatty acids, growth hormones, and cytokines, can play an important role in perinatal growth and organ system development and that this complex array of nutrients and growth factors found in both amniotic fluid and milk can contribute to early perinatal programming that can have long lasting biological consequences for development.
My objectives during this phase of my research program are to continue to investigate the biochemical development by exploring the following: (1) Is the biochemical development of the fetus/neonate predicted and regulated by specific AF fatty acids or amino acids, or polyphenols? (2) Does maternal infection, in particular gastrointestinal nematode infections, limit perinatal growth and development through overproduction of proinflammatory cytokines in either amniotic fluid and/or in breast milk and thereby modify biochemical development? (3) Can novel biomarkers in amniotic fluid, milk, and/or maternal/fetal serum emerge to identify unique metabolic profiles associated with either poor or optimal perinatal development? Implications of this research are far-reaching given that earlier identification of abnormal fetal growth and development using non-invasive biomarkers would provide the possibility for earlier screening and development of early intervention strategies.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
3623-2011
Name nom
Koski, Kristine
Department département
Dietetics and Human Nutrition, School of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
56000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6407
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Nutrition
Research subject fr
Nutrition
Partie
5
Nb partie
5
Application title
Biochemical development of the fetus and neonate and maternal diet
Keyword
NSERC
Application summary
Early nutrition plays an important role in fetal and neonatal growth and development, but surprisingly little research has investigated those nutrients and growth factors that play critical roles in these early biological processes. Historical data points to glucose as the principal metabolic fuel for the developing fetus and fetal glycogen reserves as playing a critical role in preventing neonatal morbidity and mortality including neonatal hypoglycemia. However, we now understand that early perinatal exposure to a complex array of nutrients and growth factors found in amniotic fluid (AF) and in milk, including amino acids, fatty acids, growth hormones, and cytokines, can play an important role in perinatal growth and organ system development and that this complex array of nutrients and growth factors found in both amniotic fluid and milk can contribute to early perinatal programming that can have long lasting biological consequences for development.
My objectives during this phase of my research program are to continue to investigate the biochemical development by exploring the following: (1) Is the biochemical development of the fetus/neonate predicted and regulated by specific AF fatty acids or amino acids, or polyphenols? (2) Does maternal infection, in particular gastrointestinal nematode infections, limit perinatal growth and development through overproduction of proinflammatory cytokines in either amniotic fluid and/or in breast milk and thereby modify biochemical development? (3) Can novel biomarkers in amniotic fluid, milk, and/or maternal/fetal serum emerge to identify unique metabolic profiles associated with either poor or optimal perinatal development? Implications of this research are far-reaching given that earlier identification of abnormal fetal growth and development using non-invasive biomarkers would provide the possibility for earlier screening and development of early intervention strategies.